| Weissleder, Ralph |
Massachusetts General Hospital
United States |
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN) |
5R01CA237332-03 |
PAR-16-276 (R01) |
Matthew Young, Ph.D. |
| Hanash, Samir M |
University Of Tx Md Anderson Can Ctr
United States |
Clinical Validation Center for Lung Cancer Early Detection |
1U01CA271888-01 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
Guillermo Marquez, Ph.D. |
| Hanash, Samir M |
University Of Tx Md Anderson Can Ctr
United States |
Clinical Validation Center for Lung Cancer Early Detection |
1U01CA271888-01 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
Guillermo Marquez, Ph.D. |
| Godwin, Andrew K. |
University Of Kansas Medical Center
United States |
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem |
3R01CA260132-02S1 |
|
Matthew Young, Ph.D. |
| Schoen, Robert E. |
University Of Pittsburgh At Pittsburgh
United States |
Blood-Based Testing for Advanced Adenoma |
1U01CA271884-01 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
Jo Ann Rinaudo, Ph.D. |
| Schoen, Robert E. |
University Of Pittsburgh At Pittsburgh
United States |
Blood-Based Testing for Advanced Adenoma |
1U01CA271884-01 |
RFA-CA-21-033 (U01 Clinical Trial Optional) |
Jo Ann Rinaudo, Ph.D. |
| Turesky, Robert J. |
University Of Minnesota
United States |
DNA adductomics of the urinary system |
5R01CA220367-06 |
|
Wendy Wang, Ph.D., M.Sc. |
| Roberts, Steven A |
Washington State University
United States |
Characterizing the contribution of transcription-associated DNA-topoisomerase adducts to mutagenesis in cancer |
1R21CA264086-01A1 |
PAR-19-252 (R21 Clinical Trial Optional) |
Richard Mazurchuk, Ph.D. |
| Ivanov, Alexander R. |
Northeastern University
United States |
Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection |
3R01CA218500-05S1 |
|
Matthew Young, Ph.D. |
| Grady, William Mallory |
Fred Hutchinson Cancer Center
United States |
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome |
1U54CA274374-01 |
RFA-CA-21-054 (U54 Clinical Trial Not Allowed) |
Christos Patriotis, Ph.D., M.Sc. |